Atb Cap Markets Predicts Organigram Q1 Earnings

Organigram Holdings Inc. (NASDAQ:OGI) – Equities research analysts at Atb Cap Markets issued their Q1 2025 EPS estimates for Organigram in a research report issued to clients and investors on Wednesday, December 18th. Atb Cap Markets analyst F. Gomes expects that the company will earn ($0.02) per share for the quarter. The consensus estimate for Organigram’s current full-year earnings is ($0.20) per share. Atb Cap Markets also issued estimates for Organigram’s Q2 2025 earnings at ($0.03) EPS and FY2025 earnings at ($0.07) EPS.

Organigram Price Performance

Shares of NASDAQ OGI opened at $1.58 on Monday. The company has a market cap of $199.33 million, a PE ratio of -3.76 and a beta of 1.02. The stock has a fifty day moving average price of $1.61 and a 200 day moving average price of $1.67. Organigram has a 1-year low of $1.25 and a 1-year high of $2.91.

Organigram (NASDAQ:OGI) last posted its quarterly earnings data on Wednesday, December 18th. The company reported ($0.04) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.03) by ($0.01). Organigram had a negative return on equity of 16.76% and a negative net margin of 45.57%.

Institutional Inflows and Outflows

Several large investors have recently added to or reduced their stakes in OGI. Toronto Dominion Bank boosted its holdings in Organigram by 803.7% in the 3rd quarter. Toronto Dominion Bank now owns 16,727 shares of the company’s stock valued at $30,000 after purchasing an additional 14,876 shares in the last quarter. Renaissance Technologies LLC raised its stake in shares of Organigram by 40.8% during the 2nd quarter. Renaissance Technologies LLC now owns 816,948 shares of the company’s stock worth $1,258,000 after buying an additional 236,700 shares in the last quarter. AdvisorShares Investments LLC lifted its holdings in shares of Organigram by 11.8% in the 2nd quarter. AdvisorShares Investments LLC now owns 1,000,126 shares of the company’s stock valued at $1,540,000 after buying an additional 105,468 shares during the period. Finally, Tidal Investments LLC boosted its stake in shares of Organigram by 8.3% in the third quarter. Tidal Investments LLC now owns 1,948,188 shares of the company’s stock valued at $3,526,000 after buying an additional 149,171 shares in the last quarter. 34.63% of the stock is owned by hedge funds and other institutional investors.

About Organigram

Organigram Holdings Inc, through its subsidiaries, engages in the production and sale of cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including whole flower, milled flower, pre-rolls, infused pre-rolls, vapes, gummies, and concentrates for medical retailers; adult use recreational cannabis under the SHRED, Holy Mountain, Big Bag O' Buds, Monjour, Trailblazer, SHRED'ems, Edison Cannabis Co, Edison JOLTS, Tremblant, and Laurentian brands.